In addition, a high ADRA2C expression level was associated with a favorable DSS in GBMLGG (HR=0.50, p<0.001) and UVM (HR=0.33, p=0.021) (Figures 3E and 3G), while a high ADRA2C expression level was correlated with a poor DSS in ACC (HR=2.55, p=0.028) and KIRP (HR=2.66, p=0.028) (Figures 3D and 3F). The gene discussed is ADRA2C; the disease is adrenal cortex carcinoma.